| Robyera Revoal, | |
|
63 Albemarle Ave, Ewing, NJ 08638-3501 | |
| (732) 718-5214 | |
| Not Available |
| Full Name | Robyera Revoal |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 19 Years |
| Location | 63 Albemarle Ave, Ewing, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194104844 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 37LC00217000 (New Jersey) | Secondary |
| 1041C0700X | Social Worker - Clinical | 44SC05591100 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stable Community Services | 9436374022 | 5 |
News Archive
The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment from Cancer Research UK, announced today (Monday).
Poland's entry into the EU may have had the surprising consequence of increasing allergies in rural villages, according to a new study. Surveys show that the prevalence of atopy, a predisposition towards allergic reactions, jumped from seven per cent to 20 per cent in villages in southwest Poland between 2003 and 2012.
Home Diagnostics, Inc. and Nipro Diabetes Systems, Inc. today announced that the two companies will merge to become Nipro Diagnostics, Inc. Both companies are wholly-owned by Nipro Corporation, a multi-billion dollar company headquartered in Osaka, Japan and a world leader in providing medical products to the healthcare community.
Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced financial results for the third quarter ended September 30, 2010.
› Verified 6 days ago
| Entity Name | Stable Community Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568885663 PECOS PAC ID: 9436374022 Enrollment ID: O20140716000781 |
News Archive
The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment from Cancer Research UK, announced today (Monday).
Poland's entry into the EU may have had the surprising consequence of increasing allergies in rural villages, according to a new study. Surveys show that the prevalence of atopy, a predisposition towards allergic reactions, jumped from seven per cent to 20 per cent in villages in southwest Poland between 2003 and 2012.
Home Diagnostics, Inc. and Nipro Diabetes Systems, Inc. today announced that the two companies will merge to become Nipro Diagnostics, Inc. Both companies are wholly-owned by Nipro Corporation, a multi-billion dollar company headquartered in Osaka, Japan and a world leader in providing medical products to the healthcare community.
Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced financial results for the third quarter ended September 30, 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robyera Revoal, 63 Albemarle Ave, Ewing, NJ 08638-3501 Ph: (732) 718-5214 | Robyera Revoal, 63 Albemarle Ave, Ewing, NJ 08638-3501 Ph: (732) 718-5214 |
News Archive
The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment from Cancer Research UK, announced today (Monday).
Poland's entry into the EU may have had the surprising consequence of increasing allergies in rural villages, according to a new study. Surveys show that the prevalence of atopy, a predisposition towards allergic reactions, jumped from seven per cent to 20 per cent in villages in southwest Poland between 2003 and 2012.
Home Diagnostics, Inc. and Nipro Diabetes Systems, Inc. today announced that the two companies will merge to become Nipro Diagnostics, Inc. Both companies are wholly-owned by Nipro Corporation, a multi-billion dollar company headquartered in Osaka, Japan and a world leader in providing medical products to the healthcare community.
Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced financial results for the third quarter ended September 30, 2010.
› Verified 6 days ago